An observational study in Cancer and Vaping, sponsored by Memorial Sloan Kettering Cancer Center. Enrolling by invitation at 7 sites in United States. Open to participants aged 15 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Memorial Sloan Kettering Cancer Center · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to learn more about how adolescent and young adult (AYA) cancer patients, their parents and caregivers (referred to as a carebuddy in this study), and their healthcare providers think about and communicate around vaping and tobacco use. The researchers hope this information will help them develop educational materials and provider training tools that are appropriate for young people with cancer.
A Community Advisory Board that is made up of AYA patients, parents/caregivers, and healthcare providers, is helping to guide the study. The board will review the materials, give feedback, help the study team understand the findings, and provides input to make sure the study is appropriate and practical for participants.
10,838 studies on the registry are indexed under Neoplasms; 2,322 are open to participants now.
This study's planned enrollment of 80 is below the median of 200 across 2,644 observational studies indexed under Neoplasms.
Browse Neoplasms studies →Memorial Sloan Kettering Cancer Center is the lead sponsor of 1,964 studies on the registry; 325 are open to participants now.
Of its 135 completed or terminated interventional studies of FDA-regulated products, 71 (53%) have results posted.
Counted across the registry records on this site, refreshed daily.
MSK clinics
Inclusion Criteria:
Exclusion Criteria:
Other: Study assessments
Other: Study assessments
Other: Study assessments
Patient and Parent/Carebuddy Survey, Provider Survey, AYA Patient Focus Group Guide, Parent/Caregiver Focus Group Guide. AYA patient and parent/carebuddies participants will participate in virtual focus group sessions conducted via Zoom or Microsoft Teams. Focus groups will utilize structured discussion guides informed by talk-aloud (think-aloud) methodology. The research staff will maintain communication with participants before their focus groups via call, email, text and/or MyChart before their focus groups to remind them about their upcoming focus group as well as to have their computers charged.
support needs to inform the development of developmentally appropriate vaping cessation resources.
using study assessments Survey measures will include: 1) Sociodemographic and medical characteristics (e.g., age, race/ethnicity, education, employment status/role); 2) vaping use and knowledge, including frequency of use, product type, and related perceptions; and 3) for providers only, current communication practices related to vaping use among AYA patients, perceived barriers, educational needs, and suggested adaptations to provider communication training materials.
Time frame: 1 year
Started Sep 2026 (actual). Primary completion is estimated for Sep 2027, 12 months after the start.
Of 1,099 non-industry observational studies under Neoplasms, half reached primary completion within 61 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 227. This study's planned 12 months is below that.
Counting every sponsor, half of 1,247 studies reached it within 58 months; a quarter within 24 and three quarters within 210.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Memorial Sloan Kettering Cancer Center →